Technical Analysis for OVIT - Oncovista Innovative Therapies I

Grade Last Price % Change Price Change
grade B 0.0323 -12.70% -0.0047
OVIT closed down 12.7 percent on Monday, September 14, 2020, on 46 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical OVIT trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -12.70%
Calm After Storm Range Contraction -12.70%
Narrow Range Bar Range Contraction -12.70%
Inside Day Range Contraction -12.70%
Wide Bands Range Expansion -12.70%
180 Bullish Setup Bullish Swing Setup -31.86%
Older End-of-Day Gignals for OVIT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

OncoVista Innovative Therapies, Inc. is a biopharmaceutical company. The Company is engaged in developing targeted anticancer therapies by utilizing tumor-associated biomarkers. The Company's product pipeline consists of advanced (Phase II) and early (Phase I) clinical-stage compounds, late preclinical drug candidates and early preclinical leads. The Company's therapeutic strategy is based on targeting the patient's tumors with treatments that will deliver drugs selectively based upon specific biochemical characteristics of the cancer cells comprising the tumor. The Company's products include: Cordycepin (OVI-123) and L-Nucleoside Conjugates (OVI-117). Cordycepin depends upon the presence of a DNA polymerase, known as terminal deoxynucleotidyl transferase (TdT), for its therapeutic activity. OVI-117 is a thymidylate synthase (TS) inhibitor with pharmacological properties, which results in a retention of efficacy and a reduction of toxicity.
Medicine Biotechnology Branches Of Biology Cancer Clinical Medicine Biopharmaceutical Tumor Biomarkers Chemical Pathology Cordycepin

Is OVIT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.07
52 Week Low 0.0065
Average Volume 22,672
200-Day Moving Average 0.0222
50-Day Moving Average 0.0209
20-Day Moving Average 0.0263
10-Day Moving Average 0.0378
Average True Range 0.0112
ADX 21.28
+DI 29.1774
-DI 34.5116
Chandelier Exit (Long, 3 ATRs ) 0.0364
Chandelier Exit (Short, 3 ATRs ) 0.0461
Upper Bollinger Band 0.0611
Lower Bollinger Band -0.0085
Percent B (%b) 0.59
BandWidth 264.6388
MACD Line 0.0066
MACD Signal Line 0.0053
MACD Histogram 0.0013
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0433
Resistance 3 (R3) 0.0420 0.0372 0.0414
Resistance 2 (R2) 0.0372 0.0344 0.0378 0.0408
Resistance 1 (R1) 0.0347 0.0327 0.0360 0.0360 0.0402
Pivot Point 0.0299 0.0299 0.0305 0.0305 0.0299
Support 1 (S1) 0.0274 0.0271 0.0287 0.0287 0.0244
Support 2 (S2) 0.0226 0.0254 0.0232 0.0238
Support 3 (S3) 0.0201 0.0226 0.0232
Support 4 (S4) 0.0214